Your session is about to expire
← Back to Search
Problem Solving Therapy for Suicide Prevention in Veterans
N/A
Recruiting
Led By Sherry A Beaudreau, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No current prescription for anti-psychotics if prescribed for a psychotic disorder
>= 60 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change across 11 timepoints: baseline, after each of the 6 weekly treatment sessions, posttreatment (7 weeks), 1-, 3-, and 6-month follow-up.
Awards & highlights
Study Summary
This trial will compare Suicide Safety Planning to Problem Solving Therapy in order to find which is more effective in suicide prevention for older Veterans.
Who is the study for?
This trial is for older Veterans (60+) with depression, anxiety, PTSD or similar conditions who have had suicidal thoughts but are not at imminent risk. They must be able to understand English and participate in therapy without severe cognitive impairment from dementia or recent head injury. Those with certain psychiatric disorders, substance abuse issues, unstable medical conditions, or currently in individual psychotherapy are excluded.Check my eligibility
What is being tested?
The study compares usual VA care for suicide prevention with an addition of Problem Solving Therapy (PST) to see if it better reduces suicide risk among older Veterans. PST aims to improve coping strategies and has shown promise in pilot studies for reducing late-life suicide risk.See study design
What are the potential side effects?
Problem Solving Therapy may cause emotional discomfort as individuals confront personal challenges during sessions. There might also be temporary increases in distress as participants learn new problem-solving skills.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am not currently taking anti-psychotics for a psychotic disorder.
Select...
I am 60 years old or older.
Select...
I have been diagnosed with depression, anxiety, PTSD, or similar conditions.
Select...
I have been diagnosed with depression, anxiety, or PTSD.
Select...
I have not had a head injury in the last year.
Select...
I do not have any severe or unstable long-term illnesses.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change across 11 timepoints: baseline, after each of the 6 weekly treatment sessions, posttreatment (7 weeks), 1-, 3-, and 6-month follow-up.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change across 11 timepoints: baseline, after each of the 6 weekly treatment sessions, posttreatment (7 weeks), 1-, 3-, and 6-month follow-up.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Geriatric Suicide Ideation Scale (GSIS)
Reasons for Living - Older Adult Scale (Short RFL-OA)
Secondary outcome measures
DKEFS Verbal Fluency Test
Oral Trail Making Test (OTMT)
WAIS Digit Span subtest (Digits Forward and Backward)
+1 moreOther outcome measures
Suicide attempts
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Active treatment plus EUCExperimental Treatment1 Intervention
Veterans randomized to this condition received the treatment plus EUC.
Group II: Enhanced Usual Care (EUC)Active Control1 Intervention
Active comparator (EUC only).
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,134 Total Patients Enrolled
Sherry A Beaudreau, PhDPrincipal InvestigatorVA Palo Alto Health Care System, Palo Alto, CA
1 Previous Clinical Trials
10 Total Patients Enrolled
Sherry Ann Beaudreau, PhDPrincipal InvestigatorVA Palo Alto Health Care System, Palo Alto, CA
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not currently taking anti-psychotics for a psychotic disorder.I have been diagnosed with severe OCD, bipolar disorder, or have psychotic symptoms.I am taking anti-psychotics for depression without having psychosis.I am 60 years old or older.I am currently taking anti-psychotics for a psychotic disorder, not just for depression.I am currently in therapy for a mental health issue.I have been diagnosed with dementia based on a cognitive phone test.You have had a head injury within the last year.I can see, hear, and feel well enough to participate in my treatment.I do not have depression, anxiety, or PTSD.I do not have any severe or unstable chronic illnesses.I have been diagnosed with depression, anxiety, PTSD, or similar conditions.You do not have strong thoughts or desires to harm others.I am not in individual psychotherapy but may be receiving other forms of mental health support.You have had thoughts of self-harm in the past month, as indicated by a specific questionnaire.I have been diagnosed with depression, anxiety, or PTSD.If you indicate that you plan to harm yourself or someone else, you will not be able to participate in the study.I am younger than 60 years old.I have not had a head injury in the last year.I do not have any severe or unstable long-term illnesses.You have strong thoughts or ideas about hurting other people.I am taking medication for my mental health.My senses (sight, hearing, etc.) are not good enough for tests or treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Enhanced Usual Care (EUC)
- Group 2: Active treatment plus EUC
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the recruitment period for this research still open?
"As per the information on clinicaltrials.gov, this research project is presently recruiting participants - it was initially published on January 24th 2022 and most recently edited on May 13th 2022."
Answered by AI
How many participants are being provided treatment within this experiment?
"Affirmative. Details on clinicaltrials.gov demonstrate that this medical trial, which was initiated on January 24th 2022, is in the midst of recruiting individuals to participate. To complete their research they require 150 people from 2 different sites."
Answered by AI
What are the primary objectives of this research program?
"This medical trial will employ the Reasons for Living - Older Adult Scale (Short RFL-OA) as its primary outcome, measured across 11 timepoints from baseline to 6 months posttreatment. Secondary outcomes include the Oral Trail Making Test's scores of processing speed and switching ability, the WHO Disability Assessment Schedule short form's functioning score, and DKEFS Verbal Fluency Test's total score recording response generativity and switching capacity."
Answered by AI
Who else is applying?
What state do they live in?
New York
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
What site did they apply to?
VA Palo Alto Health Care System, Palo Alto, CA
Syracuse VA Medical Center, Syracuse, NY
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger